陕西顿斯制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
97
NMPA:97
Drug Approvals
Diprophylline Injection
- Product Name
- 二羟丙茶碱注射液
- Approval Number
- 国药准字H20253581
- Approval Date
- Mar 11, 2025
NMPA
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20249677
- Approval Date
- Dec 1, 2024
NMPA
Potassium Aspartate and Magnesium Aspartatse Injection
- Product Name
- 门冬氨酸钾镁注射液
- Approval Number
- 国药准字H61020540
- Approval Date
- Feb 21, 2024
NMPA
Compound Ammonium Glycyrrhetate Injection
- Product Name
- 复方甘草酸单铵注射液
- Approval Number
- 国药准字H61023696
- Approval Date
- Feb 21, 2024
NMPA
Potassium Aspartate and Magnesium Aspartatse Injection
- Product Name
- 门冬氨酸钾镁注射液
- Approval Number
- 国药准字H61020541
- Approval Date
- Jan 25, 2024
NMPA
BCG Polysaccharide and Nucleic Acid Injection
- Product Name
- 卡介菌多糖核酸注射液
- Approval Number
- 国药准字S61020001
- Approval Date
- Dec 6, 2023
NMPA
Calcium Bromide Injection
- Product Name
- 溴化钙注射液
- Approval Number
- 国药准字H61022424
- Approval Date
- Oct 13, 2023
NMPA
Gentamicin Sulfate Injection
- Product Name
- 硫酸庆大霉素注射液
- Approval Number
- 国药准字H61021689
- Approval Date
- Jun 26, 2023
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H61021782
- Approval Date
- Jun 26, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found